ReviewFrontiers in oncology2021

Syndecans and Their Synstatins: Targeting an Organizer of Receptor Tyrosine Kinase Signaling at the Cell-Matrix Interface.

Alan C RapraegerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.